Christopher D. Ganser is VP-Regulatory Sciences at BARD C R INC /NJ/ (BCR). They have made 1 open-market trade across 1 company since 2006, most recently 2007-02-14.
CIK 0001235358
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BCR | 16,496 | $5.5M |
Shares reported on the most recent Form 4, priced at the 2007-02-15 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BCR | SELL | 2006-05-01 | 2006-05-02 | $73.88 | $1.6M | -6.4% | -2.2% | -2.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.